Despite recent major advances in developing effective vaccines against toxoplasmosis, finding new protective vaccination strategies remains a challenging and elusive goal as it is critical to prevent the disease. Over the past few years, various experimental approaches have shown that developing an effectiv...
While commenting on the need for action from pharmaceutical companies,Marijn Verhoef, Director of Operations and Research, Access to Medicine Foundation, Netherlandssaid, “Tackling the sheer scale and pace of drug resistance is a complex global health issue that will require action from pharmaceutical ...
He is a Board Member for the Consortium Québecois sur la Découverte du Médicament (CQDM), and the Residual Risk Reduction Initiative Foundation. E Ferrannini (EF) has received honoraria for speakers bureau/advisory boards from MSD, Halozyme, GlaxoSmithKline, Bristol-Myers-Squibb, AstraZeneca, ...
Despite recent major advances in developing effective vaccines against toxoplasmosis, finding new protective vaccination strategies remains a challenging and elusive goal as it is critical to prevent the disease. Over the past few years, various experime
van Akkooi is a member of the Advisory Board for, and received consultancy honoraria from, Amgen, Bristol-Myers Squibb, Neracare, Novartis, MSD-Merck, Merck-Pfizer, Pierre Fabre, Provectus, Sanofi, Sirius Medical, and 4SC. Additional information Publisher's Note Springer Nature remains neutral...
Cognitive disorders can develop as a result of a traumatic injury to the brain[11]. Depending on the area of the brain that is damaged, this can have an impact on certain aspects of cognitive function. For example, injury to the frontal lobe may impact planning and mood, while an injury...
Top Trend #1 – Drug pricing and affordability of healthcare Centered on the US but raging across the globe is a wildfire of debate and considerable emotion around the pricing of new medicines – a conflagration that shows no signs of dying out soon. ...
Just last month, the United States Food and Drug Administration (FDA)grantedbreakthrough therapy designation to Moderna and Merck's skin cancervaccine. This allows expedited development and review of drugs intended to treat serious conditions.
The US Food & Drug Administration (FDA) warns that some nitrosamines can increase the risk of cancer. Read on as we take a closer look at nitrosamines and answer questions like how they’re formed and where they’re found. We’ll also cover the difference ...
The second track of PEGS Europe 2023 is ‘Emerging targets and therapeutic approaches’, which will feature a range of sessions made up of presentations, talks and posters which address innovative approaches to the challenges of solid tumours, and advances in discovery and engineering of antibodies ...